Yuan Xu

Insider Reports History

Entity
Individual
Location
C/O Akero Therapeutics, Inc., 601 Gateway Boulevard, Suite 350, South San Francisco, CA
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yuan Xu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
FATE THERAPEUTICS INC Director Stock Option (Right to Buy) 40K $109K $2.73 Jun 7, 2024 Direct
FATE THERAPEUTICS INC Director Common Stock 8.67K $36.7K $4.23 Aug 6, 2024 Direct
Akero Therapeutics, Inc. Director Stock Option (Right to Buy) 26K Jun 8, 2024 Direct
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 25K Jun 14, 2024 Direct

Insider Reports Filed by Yuan Xu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FATE FATE THERAPEUTICS INC Aug 6, 2024 1 -$2.68K 4 Aug 7, 2024 Director
XLO Xilio Therapeutics, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
AKRO Akero Therapeutics, Inc. Jun 8, 2024 1 $0 4 Jun 11, 2024 Director
FATE FATE THERAPEUTICS INC Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
FATE FATE THERAPEUTICS INC Aug 4, 2023 1 -$2.34K 4 Aug 7, 2023 Director
AKRO Akero Therapeutics, Inc. Jun 23, 2023 1 $0 4 Jun 27, 2023 Director
FATE FATE THERAPEUTICS INC Jun 14, 2023 1 -$19.3K 4 Jun 15, 2023 Director
XLO Xilio Therapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 13, 2023 Director
FATE FATE THERAPEUTICS INC Jun 6, 2023 1 $0 4 Jun 7, 2023 Director
XLO Xilio Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
FATE FATE THERAPEUTICS INC Jun 9, 2022 2 $0 4 Jun 13, 2022 Director
AKRO Akero Therapeutics, Inc. Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
XLO Xilio Therapeutics, Inc. Jan 4, 2022 1 $0 4 Jan 6, 2022 Director
XLO Xilio Therapeutics, Inc. Jan 4, 2022 0 $0 3 Jan 6, 2022 Director
FATE FATE THERAPEUTICS INC Aug 3, 2021 2 $0 4 Aug 5, 2021 Director
FATE FATE THERAPEUTICS INC Aug 3, 2021 0 $0 3 Aug 5, 2021 Director
AKRO Akero Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director